New inhaler aims to help COPD patients breathe easier
NCT ID NCT07108699
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental inhaler called HSK39004 in 180 adults with COPD, a long-term lung disease that makes breathing hard. Participants will use the inhaler or a placebo for 4 weeks to see if it safely improves lung function. The goal is to control the disease and ease symptoms, not to cure it.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
West China Hospital of Sichuan University
Chengdu, Sichuan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New inhaled compound aims to ease COPD breathing woes
- Ultrasound might reveal hidden lung damage in COPD
- Putting Patients' priorities first: a new approach to ease the burden of multiple chronic illnesses
- Can a gentle nasal breeze unclog the Lungs' smallest airways?
- Can Home-Based lung rehab win over more COPD patients?
- Breathing battle: can simple exercises ease COPD symptoms?